Early and Midterm Major Adverse Cardiac Events in Patient With Saphenous Vein Graft Using Direct Stenting or Embolic Protection Device Stenting

BACKGROUND: The treatment of an occluded saphenous vein graft (SVG) with percutaneous coronary intervention may encounter major adverse cardiac events (MACE). MACE rates have been reduced significantly by using the embolic protection device (EPD). OBJECTIVES: The aim of this study was to clarify the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Res Cardiovasc Med
Hlavní autoři: Sadr-Ameli, Mohammadali, Mousavi, Hossein, Heidarali, Mona, Maadani, Mohsen, Ghelich, Yones, Ghadrdoost, Behshid
Médium: Artigo
Jazyk:Inglês
Vydáno: Kowsar 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4253743/
https://ncbi.nlm.nih.gov/pubmed/25478526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/cardiovascmed.13012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky